Crescent Biopharma Inc — Quarterly Balance Sheet (NASDAQ:CBIO)

Financials

Total revenue —————— — Gross profit —————— — Operating expenses 11.23 M7.33 M2.4 M32.86 M37.71 M114.16 M 187.13 M Selling/general/admin expenses 4.01 M5.08 M2.38 M8.95 M5.54 M8.52 M 25.39 M Research & development 1.72 M233.21 K14.78 K22.69 M30.96 M105.64 M 159.31 M Operating income -11.23 M-7.33 M-2.4 M37.65 M42.51 M108.12 M 185.88 M Non-Operating Income, Total 1.41 M——1.07 M2.56 M— — Interest expense, net of interest capitalized ———3.26 M2.19 M2.19 M — Non-Operating Income, excl. Interest Expenses 1.41 M——-1.43 M-907 K— — Unusual income/expense ———-760 K1.28 M— — Pretax income -9.82 M-7.33 M-2.4 M21.03 M28.44 M108.12 M 155.19 M Equity in earnings —————— — Taxes ——00069.52 M 69.52 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -9.82 M-7.22 M-2.34 M-21.79 M-24.61 M92.4 M 43.66 M Discontinued operations —————— — Net income -9.82 M-7.22 M-2.34 M-21.79 M-24.61 M92.4 M 43.66 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -9.82 M-7.22 M-2.34 M-19 M-20.95 M92.4 M 50.1 M Basic earnings per share (Basic EPS) -0.15-0.11-0.04——— — Diluted earnings per share (Diluted EPS) -0.28-0.24-0.04-38.54-8.5157.77 — Average basic shares outstanding 64.48 M64.48 M64.52 M——— — Diluted shares outstanding 64.48 M64.48 M64.52 M565.44 K2.89 M1.6 M 69.58 M EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 8 1310———— —